Thermo Fisher Scientific
Thermo Fisher Gets FDA Emergency Use Authorization for Pooled Sample SARS-CoV-2 Test Kit
The RT-PCR-based kit is designed to detect SARS-CoV-2 nucleic acid in pooled samples containing up to five individual nasal swab specimens.
In Brief This Week: Roche Diagnostics, Amazon, Illumina, Sera Prognostics, and More
News items for the in vitro diagnostics industry for the week of May 17, 2021.
Thermo Fisher Scientific Q1 Revenues up 59 Percent
The firm said revenues from its life sciences solutions segment more than doubled during the quarter, while revenues from specialty diagnostics rose 69 percent.
Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B
Thermo Fisher will acquire PPD for $47.50 per share for a total price of $17.4 billion, plus the assumption of approximately $3.5 billion in debt.
FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines
Premium
The researchers found that the reliable sampling of rare circulating tumor DNA fragments served as the key challenge for developing liquid biopsy assays.
Feb 19, 2021